Can telemedicine help prevent blindness in diabetes patients?
NCT ID NCT05773495
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a program called I-SITE that helps clinics use teleophthalmology—taking eye photos during regular doctor visits—to increase screening for diabetic retinopathy. Over 12,000 patients with diabetes from urban health systems are included. The goal is to see if this approach leads to more people getting their eyes checked regularly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show how to make diabetic eye screening more routine and accessible, potentially preventing vision loss in many patients.
- What could go wrong
- This is an implementation study, not a test of a new treatment. It may not change screening rates significantly, and results may not apply to all clinics.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Wisconsin
Madison, Wisconsin, 53705, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI eye doctor: could software catch diabetic blindness sooner?
- Can eye scans reveal hidden clues about diabetes damage?
- AI could predict which eye treatments work best for Diabetes-Related vision loss
- New eye drug aims to restore vision in Diabetes-Related swelling
- New eye drug aims to restore vision in Diabetes-Related swelling
- Eye scans could spot Diabetes-Related vision damage years early